The clinical development of p53-reactivating drugs in sarcomas - charting future therapeutic approaches and understanding the clinical molecular toxicology of Nutlins.
Saved in:
| Title: | The clinical development of p53-reactivating drugs in sarcomas - charting future therapeutic approaches and understanding the clinical molecular toxicology of Nutlins. |
|---|---|
| Authors: | Biswas S; University Hospitals Southampton NHS Foundation Trust, Southampton General Hospital, Division of Medical Oncology, Sarcoma Unit , Floor D, East Wing, Southampton, Tremona Road, Southampton, SO16 6YD , UK swethajit.biswas@uhs.nhs.uk., Killick E, Jochemsen AG, Lunec J |
| Source: | Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2014 May; Vol. 23 (5), pp. 629-45. Date of Electronic Publication: 2014 Feb 28. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7658 (Electronic) Linking ISSN: 13543784 NLM ISO Abbreviation: Expert Opin Investig Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 24579771 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The clinical development of p53-reactivating drugs in sarcomas - charting future therapeutic approaches and understanding the clinical molecular toxicology of Nutlins. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Biswas+S%22">Biswas S</searchLink>; University Hospitals Southampton NHS Foundation Trust, Southampton General Hospital, Division of Medical Oncology, Sarcoma Unit , Floor D, East Wing, Southampton, Tremona Road, Southampton, SO16 6YD , UK swethajit.biswas@uhs.nhs.uk.<br /><searchLink fieldCode="AU" term="%22Killick+E%22">Killick E</searchLink><br /><searchLink fieldCode="AU" term="%22Jochemsen+AG%22">Jochemsen AG</searchLink><br /><searchLink fieldCode="AU" term="%22Lunec+J%22">Lunec J</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229434197%22">Expert opinion on investigational drugs</searchLink> [Expert Opin Investig Drugs] 2014 May; Vol. 23 (5), pp. 629-45. <i>Date of Electronic Publication: </i>2014 Feb 28. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9434197 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-7658 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213543784%22">13543784 </searchLink><i>NLM ISO Abbreviation: </i>Expert Opin Investig Drugs <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=24579771 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1517/13543784.2014.892924 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 629 Titles: – TitleFull: The clinical development of p53-reactivating drugs in sarcomas - charting future therapeutic approaches and understanding the clinical molecular toxicology of Nutlins. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Biswas S – PersonEntity: Name: NameFull: Killick E – PersonEntity: Name: NameFull: Jochemsen AG – PersonEntity: Name: NameFull: Lunec J IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2014 May Type: published Y: 2014 Identifiers: – Type: issn-electronic Value: 1744-7658 Numbering: – Type: volume Value: 23 – Type: issue Value: 5 Titles: – TitleFull: Expert opinion on investigational drugs Type: main |
| ResultId | 1 |
